Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Pharmaceutical Verification Pilot

14 Jul 2016 07:00

RNS Number : 1316E
Crimson Tide PLC
14 July 2016
 

Crimson Tide PLC

 

("Crimson Tide" or the 'Company')

 

Crimson Tide selected for pharmaceutical verification pilot

 

Crimson Tide (TIDE), the AIM-quoted provider of mpro5 - Smart Mobility as a Service, has won a contract for the initial stage of a significant healthcare pilot project in Asia for the serialisation and verification of pharmaceutical products. The pilot project is being implemented under the auspices of the Asia Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF), Committee on Trade and Investment (CTI) and Business Advisory Council (ABAC).

 

Selected by a consortium of pharma organisations, the technology platform for the demonstration phase of the pilot project will leverage mpro5 to scan pharmaceutical products, generating an anonymous verification request to the product's manufacturer. The pilot project seeks to demonstrate for the first time the ability to verify serialised pharmaceutical products from various scan locations to source data stored in distributed databases using global data standards. The pilot also seeks to promote harmonisation by demonstrating the ability to use a single or reproducible data gateway in multiple countries.

 

mpro5 provides barcode scanning and cloud-based synchronisation services via Microsoft Azure, renowned for its reliability, scalability and security. This enables real-time information upload, quick verifications and multi-way data request transmittals.

 

Barrie Whipp, Executive Chairman of Crimson Tide, said: "The global impact of drug serialisation and verification cannot be underestimated. I am delighted that we have been chosen to help in this pilot project in Asia, as it opens up significant opportunities in the pharma world."

 

ends

 

For further information:

 

Crimson Tide plc

 

Barrie Whipp 01892 542 444

Steve Goodwin

 

WH Ireland

 

James Joyce /James Bavister 020 7220 1666

Allerton Communications

Peter Curtain 020 3137 2500

peter.curtain@allertoncomms.co.uk 

 

Notes to editors

Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 - Smart Mobility as a Service (SMaaS). mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces.

Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world-class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money.

mpro5 is a platform-agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment.

mpro5 not only helps people improve their day-to-day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTEAPXDFFLKEFF
Date   Source Headline
26th Apr 20137:00 amRNSFinal Results
11th Apr 20137:00 amRNSContract Wins with Associated Newspapers for Metro
9th Apr 201310:08 amRNSHolding(s) in Company
29th Jan 201312:32 pmRNSHolding(s) in Company
13th Nov 20127:00 amRNSContract Win to Develop App for Autism Sufferers
17th Oct 20127:00 amRNSSigned agreement with Microsoft
27th Sep 20127:00 amRNSInterim Results
24th Sep 201212:51 pmRNSHolding(s) in Company
19th Sep 20127:00 amRNSMPRO5 Upgrade and Contract Wins
5th Sep 20127:00 amRNSHolding(s) in Company
13th Aug 201210:49 amRNSAppointment of Director
29th Jun 201211:14 amRNSResult of Meeting
28th Jun 20125:09 pmRNSResult of AGM
21st Jun 20127:00 amRNSContract Extension
7th Jun 20127:00 amRNSContract Win
6th Jun 20127:00 amRNSPosting of Final Accounts and Notice of AGM
16th May 20127:00 amRNSContract Wins
10th May 20127:03 amRNSFinal Results
9th May 201212:35 pmRNSHolding(s) in Company
1st May 20127:00 amRNSCrimson Tide contract with Euro Food Brands
24th Apr 20127:00 amRNSHaemophiliac Home Treatment Update
5th Dec 20114:25 pmRNSDirector/PDMR Shareholding
29th Sep 20117:00 amRNSHalf Yearly Report
12th Sep 20117:00 amRNSPremier Telecoms Agreement
20th Jul 20117:00 amRNSSTRATEGIC PARTNERSHIP WITH CRIMSON TIDE PLC
20th Jul 20117:00 amRNSStrategic Partnership
29th Jun 201112:27 pmRNSResult of AGM
6th Jun 20114:03 pmRNSAnnual Report and Notice of AGM
31st May 20117:54 amRNSTotal Voting Rights
12th May 20117:01 amRNSExercise of option and repayment of debt
12th May 20117:00 amRNSFinal Results
19th Apr 20117:00 amRNSChange of Adviser
16th Feb 201111:59 amRNSHolding(s) in Company
15th Feb 20117:00 amRNSHolding(s) in Company
4th Feb 20117:00 amRNSHolding(s) in Company
31st Jan 20117:00 amRNSContract with Associated Newspapers
17th Jan 20117:00 amRNSIssue of Equity
17th Nov 201011:09 amRNSHolding(s) in Company
14th Oct 20107:00 amRNSIssue of Equity
28th Sep 20107:00 amRNSHalf Yearly Report
31st Aug 20107:01 amRNSCrimson Tide wins first South African Contract
29th Jun 20102:39 pmRNSResult of AGM
2nd Jun 20107:00 amRNSAnnual Financial Report
10th May 20107:00 amRNSFirst Own Brand Mobile Software Product
7th May 20102:50 pmRNSGrant of Options
13th Apr 20107:00 amRNSPreliminary Results
9th Apr 20107:00 amRNSContract Win
7th Apr 20107:00 amRNSTechnology provider for study on ageing
18th Mar 20103:37 pmRNSExtension of Loan Facility
2nd Mar 20107:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.